Global languages
2022-04-19
Regulatory

CellaVision publishes its 2021 Annual and Sustainability Report

Today, CellaVision announced that the company's Annual and Sustainability Report for 2021 is available as PDF at www.cellavision.com and can be read via the link below.

The company has decided to print the 2021 Annual and Sustainability Report in a small number of copies in accordance with the company's environmental policy. To request a printed version, please visit the investor pages at CellaVision's website.

Contact

Adele Horn
Corporate Communications & Investor Relations
Direct: +46 (0) 464 602 604
Mobile: +46 (0) 722 065 088

About Us

CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products replace manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in sample preparation, image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the parent company in Lund and by the company´s 17 local market support organizations covering more than 40 countries. In 2021, sales were SEK 566 million and the company's growth target is 15% per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Mid Cap list. Read more at www.cellavision.com

This information is information that CellaVision is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-04-19 08:20 CEST.

Attachments

CellaVision Annual And Sustainability Report 2021

Share